| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A case of mistaken identity? Vaccinia virus in a live camelpox vaccine
|
Yousif, A.A.
|
|
2012
|
|
6 |
p. 495-498
4 p.
|
article
|
| 2 |
Acknowledgements
|
Gaudry, Daniel
|
|
2009
|
|
6 |
p. 356-
1 p.
|
article
|
| 3 |
Aims and Scope/Editorial Board/Publishing Details
|
|
|
2009
|
|
6 |
p. IFC-
1 p.
|
article
|
| 4 |
Aims and Scope/Editorial Board/Publishing Details
|
|
|
2016
|
|
6 |
p. IFC-
1 p.
|
article
|
| 5 |
Aims and Scope/Editorial Board/Publishing Details
|
|
|
2014
|
|
6 |
p. IFC-
1 p.
|
article
|
| 6 |
Aims and Scope/Editorial Board/Publishing Details
|
|
|
2010
|
|
6 |
p. IFC-
1 p.
|
article
|
| 7 |
Aims and Scope/Editorial Board/Publishing Details
|
|
|
2008
|
|
6 |
p. IFC-
1 p.
|
article
|
| 8 |
Aims and Scope/Editorial Board/Publishing Details
|
|
|
2012
|
|
6 |
p. IFC-
1 p.
|
article
|
| 9 |
Aims and Scope/Editorial Board/Publishing Details
|
|
|
2015
|
|
6 |
p. IFC-
1 p.
|
article
|
| 10 |
Aims and Scope/Editorial Board/Publishing Details
|
|
|
2013
|
|
6 |
p. IFC-
1 p.
|
article
|
| 11 |
Aims and Scope/Editorial Board/Publishing Details
|
|
|
2011
|
|
6 |
p. IFC-
1 p.
|
article
|
| 12 |
Allogeneic mesenchymal stem cell infusion for the stabilization of focal segmental glomerulosclerosis
|
Belingheri, Mirco
|
|
2013
|
|
6 |
p. 439-445
7 p.
|
article
|
| 13 |
A multi-dose serological assay suitable to quantify the potency of inactivated rabies vaccines for veterinary use
|
Krämer, Beate
|
|
2013
|
|
6 |
p. 400-406
7 p.
|
article
|
| 14 |
Anamnestic immunological response profile in laboratory animals after immunization with recombinant hepatitis B vaccines of different generations
|
Górska, Paulina
|
|
2012
|
|
6 |
p. 431-438
8 p.
|
article
|
| 15 |
An annual vaccine: Seasonal influenza
|
Jivapaisarnpong, Teeranart
|
|
2009
|
|
6 |
p. 410-411
2 p.
|
article
|
| 16 |
A non-innovator version of etanercept for treatment of arthritis
|
Maity, Sunit
|
|
2011
|
|
6 |
p. 384-395
12 p.
|
article
|
| 17 |
A novel monoclonal antibody to Neisseria meningitidis serogroup X capsular polysaccharide and its potential use in quantitation of meningococcal vaccines
|
Reyes, Fátima
|
|
2014
|
|
6 |
p. 312-315
4 p.
|
article
|
| 18 |
An overview of animal cell substrates for biological products
|
Petricciani, John
|
|
2008
|
|
6 |
p. 359-362
4 p.
|
article
|
| 19 |
Antigen content versus volume of rabies vaccines administered intradermally
|
Dodet, B.
|
|
2011
|
|
6 |
p. 444-445
2 p.
|
article
|
| 20 |
Antimicrobial potential of phylogenetically unique actinomycete, Streptomyces sp. JRG-04 from marine origin
|
Govindarajan, Ganesan
|
|
2014
|
|
6 |
p. 305-311
7 p.
|
article
|
| 21 |
Applicability of bacterial endotoxins test to various blood products by the use of endotoxin-specific lysates
|
Ochiai, Masaki
|
|
2010
|
|
6 |
p. 629-636
8 p.
|
article
|
| 22 |
Application of a real time Polymerase Chain Reaction (PCR) assay for the early diagnosis of human leptospirosis in Sri Lanka
|
Denipitiya, D.T.H.
|
|
2016
|
|
6 |
p. 497-502
6 p.
|
article
|
| 23 |
Application of different downstream processing methods and their comparison for the large-scale preparation of Bacillus thuringiensis var. israelensis after fermentation for mosquito control
|
Prabakaran, G.
|
|
2008
|
|
6 |
p. 412-415
4 p.
|
article
|
| 24 |
Application of the Three Rs to challenge assays used in vaccine testing: Tenth report of the BVAAWF/FRAME/RSPCA/UFAW Joint Working Group on Refinement
|
Jennings, Maggy
|
|
2010
|
|
6 |
p. 684-695
12 p.
|
article
|
| 25 |
A two-stage, multilevel quality control system for serological assays in anthrax vaccine clinical trials
|
Soroka, Stephen D.
|
|
2010
|
|
6 |
p. 675-683
9 p.
|
article
|
| 26 |
A vaccine measured with a highly variable assay: Rabies
|
Jivapaisarnpong, Teeranart
|
|
2009
|
|
6 |
p. 412-415
4 p.
|
article
|
| 27 |
Basic principles of stability
|
Egan, William
|
|
2009
|
|
6 |
p. 379-386
8 p.
|
article
|
| 28 |
Calibration and commutability assessment of the 1st International Standard for Diphtheria Antitoxin Human
|
Stickings, Paul
|
|
2013
|
|
6 |
p. 384-392
9 p.
|
article
|
| 29 |
Capacity of the manufacturing process of Flebogamma® DIF, a new human high purity intravenous immunoglobulin, to remove a TSE model-agent
|
Diez, José M.
|
|
2010
|
|
6 |
p. 670-674
5 p.
|
article
|
| 30 |
Characterization of Vibrio parahaemolyticus and its specific phage from shrimp pond in Palk Strait, South East coast of India
|
Stalin, Nattan
|
|
2016
|
|
6 |
p. 526-533
8 p.
|
article
|
| 31 |
Chicken anemia virus and avian gyrovirus 2 as contaminants in poultry vaccines
|
Varela, Ana Paula Muterle
|
|
2014
|
|
6 |
p. 346-350
5 p.
|
article
|
| 32 |
Chinese plasma-derived products supply under the lot release management system in 2007–2011
|
Zhang, Xuejun
|
|
2013
|
|
6 |
p. 364-367
4 p.
|
article
|
| 33 |
Classification and characterization of a laboratory chicken rotavirus strain carrying G7P[35] neutralization antigens on the genotype 4 backbone gene configuration
|
Papp, Hajnalka
|
|
2014
|
|
6 |
p. 299-304
6 p.
|
article
|
| 34 |
Collaborative study for the calibration of a replacement International Standard for diphtheria toxoid for use in flocculation test
|
Coombes, Laura
|
|
2016
|
|
6 |
p. 556-566
11 p.
|
article
|
| 35 |
Collaborative study for the calibration of a replacement International Standard for Tetanus Toxoid Adsorbed
|
Tierney, Rob
|
|
2011
|
|
6 |
p. 404-416
13 p.
|
article
|
| 36 |
Collaborative study report: Evaluation of the ATCC experimental mycoplasma reference strains panel prepared for comparison of NAT-based and conventional mycoplasma detection methods
|
Dabrazhynetskaya, Alena
|
|
2013
|
|
6 |
p. 377-383
7 p.
|
article
|
| 37 |
Collaborative study to establish a proficiency panel of hepatitis B surface antigens for evaluating in vitro diagnostics
|
Wang, Kun-Teng
|
|
2012
|
|
6 |
p. 445-450
6 p.
|
article
|
| 38 |
Combined vaccines – Case study
|
Jivapisarnpong, Teeranart
|
|
2009
|
|
6 |
p. 416-
1 p.
|
article
|
| 39 |
Comparability studies of new 3rd generation recombinant human factor VIII GreenGene F after improvement of formulation and viral inactivation/removal process
|
Paik, Sang Hoon
|
|
2012
|
|
6 |
p. 405-414
10 p.
|
article
|
| 40 |
Comparative efficacy of live replicating sheeppox vaccine strains in Ovines
|
Yogisharadhya, R.
|
|
2011
|
|
6 |
p. 417-423
7 p.
|
article
|
| 41 |
Comparative efficacy of virus like particle (VLP) vaccine of foot-and-mouth-disease virus (FMDV) type O adjuvanted with poly I:C or CpG in guinea pigs
|
Terhuja, Megolhubino
|
|
2015
|
|
6 |
p. 437-443
7 p.
|
article
|
| 42 |
Consideration on a few aspects of the stability studies post licensure
|
Pierard, I.
|
|
2009
|
|
6 |
p. 403-406
4 p.
|
article
|
| 43 |
Construction and immunogenic properties of a chimeric protein comprising CfaE, CfaB and LTB against Enterotoxigenic Escherichia coli
|
Gheibi Hayat, Seyed-Mohammad
|
|
2016
|
|
6 |
p. 503-510
8 p.
|
article
|
| 44 |
Detection of contaminants in cell cultures, sera and trypsin
|
Pinheiro de Oliveira, Tatiana Flávia
|
|
2013
|
|
6 |
p. 407-414
8 p.
|
article
|
| 45 |
Detection of RD-114 virus by a reverse transcriptase assay based on product enhancement
|
Narushima, Rie
|
|
2012
|
|
6 |
p. 421-425
5 p.
|
article
|
| 46 |
Determination of galactosamine impurities in heparin sodium using fluorescent labeling and conventional high-performance liquid chromatography
|
Itoh, Satsuki
|
|
2013
|
|
6 |
p. 355-363
9 p.
|
article
|
| 47 |
Development and application of HPLC-RI and HPLC-MS/MS based methods for quantification of residual deoxycholate levels in pneumococcal polysaccharides
|
Gairola, Sunil
|
|
2016
|
|
6 |
p. 517-525
9 p.
|
article
|
| 48 |
Development and preliminary validation of an antibody filtration-assisted single-dilution chemiluminometric immunoassay for potency testing of Piscirickettsia salmonis vaccines
|
Wilda, Maximiliano
|
|
2012
|
|
6 |
p. 415-420
6 p.
|
article
|
| 49 |
Development of a novel recombinant influenza vaccine in insect cells
|
McPherson, Clifton E.
|
|
2008
|
|
6 |
p. 350-353
4 p.
|
article
|
| 50 |
Development of a simple method for the rapid identification of organisms causing anthrax by coagglutination test
|
Sumithra, T.G.
|
|
2014
|
|
6 |
p. 316-321
6 p.
|
article
|
| 51 |
Development of inactivated poliovirus vaccine from Sabin strains: A progress report
|
Okayasu, Hiromasa
|
|
2016
|
|
6 |
p. 581-587
7 p.
|
article
|
| 52 |
Domain III peptides from flavivirus envelope protein are useful antigens for serologic diagnosis and targets for immunization
|
Chávez, Juliana Helena
|
|
2010
|
|
6 |
p. 613-618
6 p.
|
article
|
| 53 |
Effectiveness of mouse minute virus inactivation by high temperature short time treatment technology: A statistical assessment
|
Murphy, Marie
|
|
2011
|
|
6 |
p. 438-443
6 p.
|
article
|
| 54 |
Enhanced potency of individual and bivalent DNA replicon vaccines or conventional DNA vaccines by formulation with aluminum phosphate
|
Yu, Yun-Zhou
|
|
2010
|
|
6 |
p. 658-663
6 p.
|
article
|
| 55 |
Enhancement of stem cell differentiation to osteogenic lineage on hydroxyapatite-coated hybrid PLGA/gelatin nanofiber scaffolds
|
Sanaei-rad, Parisa
|
|
2016
|
|
6 |
p. 511-516
6 p.
|
article
|
| 56 |
Evaluation of accuracy and reliability of the plaque reduction neutralization test (micro-PRNT) in detection of yellow fever virus antibodies
|
Simões, Marisol
|
|
2012
|
|
6 |
p. 399-404
6 p.
|
article
|
| 57 |
Evaluation of a microfluidic chip system for preparation of bacterial DNA from swabs, air, and surface water samples
|
Julich, Sandra
|
|
2016
|
|
6 |
p. 574-580
7 p.
|
article
|
| 58 |
Evaluation of an in vitro assay system as a potential alternative to current histamine sensitization test for acellular pertussis vaccines
|
Xing, Dorothy
|
|
2012
|
|
6 |
p. 456-465
10 p.
|
article
|
| 59 |
Evaluation of Fourth International Standard for Whole Cell Pertussis Vaccine
|
Das, R. Gaines
|
|
2010
|
|
6 |
p. 644-651
8 p.
|
article
|
| 60 |
Evaluation of infectious bursal disease virus stability at different conditions of temperature and pH
|
Rani, Surabhi
|
|
2015
|
|
6 |
p. 515-518
4 p.
|
article
|
| 61 |
Evaluation of the human host range of bovine and porcine viruses that may contaminate bovine serum and porcine trypsin used in the manufacture of biological products
|
Marcus-Sekura, Carol
|
|
2011
|
|
6 |
p. 359-369
11 p.
|
article
|
| 62 |
Evaluation of tumorigenic potential of high yielding cloned MDCK cells for live-attenuated influenza vaccine using in vitro growth characteristics, metastatic gene expression and in vivo nude mice model
|
Vepachedu, Ramarao S.
|
|
2012
|
|
6 |
p. 482-494
13 p.
|
article
|
| 63 |
Excipient exchange in the comparison of preparations of the same biologic made by different manufacturing processes: An exploratory study with recombinant human growth hormone (rhGH)
|
Cauchy, Mike
|
|
2010
|
|
6 |
p. 637-643
7 p.
|
article
|
| 64 |
Flebogamma® DIF (intravenous immunoglobulin) purification process effectively eliminates procoagulant activities
|
José, Marta
|
|
2013
|
|
6 |
p. 393-399
7 p.
|
article
|
| 65 |
Gamma irradiation of animal sera for inactivation of viruses and mollicutes – A review
|
Nims, Raymond W.
|
|
2011
|
|
6 |
p. 370-377
8 p.
|
article
|
| 66 |
Glycan analysis of glycoprotein pharmaceuticals: Evaluation of analytical approaches to Z number determination in pharmaceutical erythropoietin products
|
Yuen, Chun-Ting
|
|
2011
|
|
6 |
p. 396-403
8 p.
|
article
|
| 67 |
Goals of stability evaluation throughout the vaccine life cycle
|
Krause, Philip R.
|
|
2009
|
|
6 |
p. 369-378
10 p.
|
article
|
| 68 |
Guidelines on stability evaluation of vaccines
|
|
|
2009
|
|
6 |
p. 424-434
11 p.
|
article
|
| 69 |
Health Canada/BIOTECanada Summit on regulatory and clinical topics related to subsequent entry biologics (biosimilars), Ottawa, Canada, 14 May 2012
|
Kay, Jonathan
|
|
2012
|
|
6 |
p. 517-527
11 p.
|
article
|
| 70 |
High-throughput genotyping system as a robust and useful tool in oncology: Experience from a single institution
|
Henríquez-Hernández, Luis Alberto
|
|
2013
|
|
6 |
p. 424-429
6 p.
|
article
|
| 71 |
Immunopotentiation of outer membrane protein through anti-idiotype Pasteurella multocida vaccine in rabbits
|
Arif, Javid
|
|
2013
|
|
6 |
p. 339-344
6 p.
|
article
|
| 72 |
Inactivation and removal of influenza A virus H1N1 during the manufacture of plasma derivatives
|
Jeong, Eun Kyo
|
|
2010
|
|
6 |
p. 652-657
6 p.
|
article
|
| 73 |
International collaborative study for establishment of the 2nd WHO International Standard for Haemophilus influenzae type b polysaccharide
|
Mawas, Fatme
|
|
2015
|
|
6 |
p. 492-503
12 p.
|
article
|
| 74 |
Intravenous administration of equine-derived whole IgG antivenom does not induce early adverse reactions in non-envenomed horses and cows
|
Estrada, Ricardo
|
|
2010
|
|
6 |
p. 664-669
6 p.
|
article
|
| 75 |
Invert biopanning: A novel method for efficient and rapid isolation of scFvs by phage display technology
|
Rahbarnia, Leila
|
|
2016
|
|
6 |
p. 567-573
7 p.
|
article
|
| 76 |
Investigation of xenotropic murine leukemia virus-related virus (XMRV) in human and other cell lines
|
Williams, Dhanya K.
|
|
2011
|
|
6 |
p. 378-383
6 p.
|
article
|
| 77 |
In vitro antigen ELISA for quality control of tetanus vaccines
|
Coombes, Laura
|
|
2012
|
|
6 |
p. 466-472
7 p.
|
article
|
| 78 |
Isolation of scFv antibody fragments against HER2 and CEA tumor antigens from combinatorial antibody libraries derived from cancer patients
|
Ayat, Hoda
|
|
2013
|
|
6 |
p. 345-354
10 p.
|
article
|
| 79 |
Maintenance of vaccine stability through annual stability and comparability studies
|
Schofield, Timothy L.
|
|
2009
|
|
6 |
p. 397-402
6 p.
|
article
|
| 80 |
Marker vaccine potential of foot-and-mouth disease virus with large deletion in the non-structural proteins 3A and 3B
|
Biswal, Jitendra K.
|
|
2015
|
|
6 |
p. 504-511
8 p.
|
article
|
| 81 |
Measuring the effectiveness of gaseous virus disinfectants
|
Knotzer, Simone
|
|
2015
|
|
6 |
p. 519-523
5 p.
|
article
|
| 82 |
Model format for a vaccine stability report and software solutions
|
Shin, Jinho
|
|
2009
|
|
6 |
p. 417-420
4 p.
|
article
|
| 83 |
New Cells for New Vaccines II: Focus on Respiratory Virus Diseases
|
Egan, William
|
|
2008
|
|
6 |
p. 345-
1 p.
|
article
|
| 84 |
NEW technologies for meeting the global demand for pandemic influenza vaccines
|
Fedson, David S.
|
|
2008
|
|
6 |
p. 346-349
4 p.
|
article
|
| 85 |
Novel polyacrylate-based cationic nanoparticles for survivin siRNA delivery combined with mitoxantrone for treatment of breast cancer
|
Arami, Sanam
|
|
2016
|
|
6 |
p. 487-496
10 p.
|
article
|
| 86 |
Optimization and validation of ELISA immunoassay for the evaluation of in-vitro relative potency of a four-component human papillomavirus vaccine products
|
Mostafa, Moushira M.
|
|
2016
|
|
6 |
p. 596-599
4 p.
|
article
|
| 87 |
Panel discussion
|
Smith, Dean
|
|
2009
|
|
6 |
p. 421-423
3 p.
|
article
|
| 88 |
Physicochemical and biological assays for quality control of biopharmaceuticals: Interferon alfa-2 case study
|
Silva, Marta M.C.G.
|
|
2008
|
|
6 |
p. 383-392
10 p.
|
article
|
| 89 |
Plants as biofactories
|
Mett, Vadim
|
|
2008
|
|
6 |
p. 354-358
5 p.
|
article
|
| 90 |
Porcine granulocyte-colony stimulating factor (G-CSF) delivered via replication-defective adenovirus induces a sustained increase in circulating peripheral blood neutrophils
|
Loving, Crystal L.
|
|
2013
|
|
6 |
p. 368-376
9 p.
|
article
|
| 91 |
Potency estimation of vaccine batches remains unaffected by anesthesia for intracerebral injection
|
Kamphuis, Elisabeth
|
|
2012
|
|
6 |
p. 451-455
5 p.
|
article
|
| 92 |
Predictive markers of safety and immunogenicity of adjuvanted vaccines
|
Mastelic, Beatris
|
|
2013
|
|
6 |
p. 458-468
11 p.
|
article
|
| 93 |
Preparation and use of therapeutic antibodies primarily of human origin
|
Stiehm, E. Richard
|
|
2008
|
|
6 |
p. 363-374
12 p.
|
article
|
| 94 |
Prion depletion and preservation of biological activity by preparative chaotrope ultracentrifugation
|
Seeger, Harald
|
|
2008
|
|
6 |
p. 403-411
9 p.
|
article
|
| 95 |
Process optimization for an industrial-scale production of Diphtheria toxin by Corynebacterium diphtheriae PW8
|
Suwanpatcharakul, Maethichai
|
|
2016
|
|
6 |
p. 534-539
6 p.
|
article
|
| 96 |
Production and characterization of single-chain antibody (scFv) against 3ABC non-structural protein in Escherichia coli for sero-diagnosis of Foot and Mouth Disease virus
|
Sharma, Gaurav K.
|
|
2014
|
|
6 |
p. 339-345
7 p.
|
article
|
| 97 |
Production of a truncated recombinant HA1 for influenza A H9 subtype screening
|
Tombari, Wafa
|
|
2016
|
|
6 |
p. 546-555
10 p.
|
article
|
| 98 |
Rabies vaccine response measurement is assay dependent
|
Moore, Susan M.
|
|
2016
|
|
6 |
p. 481-486
6 p.
|
article
|
| 99 |
Rational design of stable and functional hirudin III mutants with lower antigenicity
|
Asgari, Saeme
|
|
2015
|
|
6 |
p. 479-491
13 p.
|
article
|
| 100 |
Recombinant human LCAT normalizes plasma lipoprotein profile in LCAT deficiency
|
Simonelli, Sara
|
|
2013
|
|
6 |
p. 446-449
4 p.
|
article
|
| 101 |
Removal of xenotropic murine leukemia virus by nanocellulose based filter paper
|
Asper, M.
|
|
2015
|
|
6 |
p. 452-456
5 p.
|
article
|
| 102 |
Reverse vaccinology as an approach for developing Histophilus somni vaccine candidates
|
Madampage, Claudia Avis
|
|
2015
|
|
6 |
p. 444-451
8 p.
|
article
|
| 103 |
Root cause investigation of a viral contamination incident occurred during master cell bank (MCB) testing and characterization – A case study
|
Chen, Dayue
|
|
2008
|
|
6 |
p. 393-402
10 p.
|
article
|
| 104 |
Save the Date
|
|
|
2011
|
|
6 |
p. 446-
1 p.
|
article
|
| 105 |
Sequence analysis of capsid coding region of foot-and-mouth disease virus type A vaccine strain during serial passages in BHK-21 adherent and suspension cells
|
Anil, K.U.
|
|
2012
|
|
6 |
p. 426-430
5 p.
|
article
|
| 106 |
Serological evidence of avian encephalomyelitis virus infection associated with vertical transmission in chicks
|
Yu, Xiao-hui
|
|
2015
|
|
6 |
p. 512-514
3 p.
|
article
|
| 107 |
Spectrum of Newcastle disease virus stability in gradients of temperature and pH
|
Rani, Surabhi
|
|
2014
|
|
6 |
p. 351-354
4 p.
|
article
|
| 108 |
Stability evaluation of vaccines
|
Schofield, Timothy
|
|
2009
|
|
6 |
p. 355-
1 p.
|
article
|
| 109 |
Stability evaluation of vaccines: WHO approach
|
Knezevic, Ivana
|
|
2009
|
|
6 |
p. 357-359
3 p.
|
article
|
| 110 |
Stability of vaccines – Bridging from stability data to continuous safety and efficacy throughout shelf life – An always reliable approach?
|
Pfleiderer, Michael
|
|
2009
|
|
6 |
p. 364-368
5 p.
|
article
|
| 111 |
Stability post-licensure: Compatibility container content – A practical case study
|
Duchêne, M.
|
|
2009
|
|
6 |
p. 407-409
3 p.
|
article
|
| 112 |
Stability testing of vaccines: Developing Countries Vaccine Manufacturers' Network (DCVMN) perspective
|
Jadhav, Suresh S.
|
|
2009
|
|
6 |
p. 360-363
4 p.
|
article
|
| 113 |
Stabilization of a recombinant human epidermal growth factor parenteral formulation through freeze-drying
|
Santana, Héctor
|
|
2014
|
|
6 |
p. 322-333
12 p.
|
article
|
| 114 |
Standardization of therapeutic, urinary gonadotrophins: An update on the use and availability of International Standards for Menotrophin
|
Ferguson, Jackie
|
|
2013
|
|
6 |
p. 435-438
4 p.
|
article
|
| 115 |
Statistical evaluations of viral clearance studies for biological products
|
Li, Na
|
|
2012
|
|
6 |
p. 439-444
6 p.
|
article
|
| 116 |
Structural, phenotypic and functional maturation of bone marrow dendritic cells (BMDCs) induced by Chitosan (CTS)
|
Jia, Lihui
|
|
2014
|
|
6 |
p. 334-338
5 p.
|
article
|
| 117 |
Study of twenty preparations of human albumin solution which failed in quality control testing due to elevated sodium content, a poor internal quality control at manufacturing unit
|
Prasad, J.P.
|
|
2016
|
|
6 |
p. 591-595
5 p.
|
article
|
| 118 |
Subvisible (2–100 μm) particle analysis during biotherapeutic drug product development: Part 2, experience with the application of subvisible particle analysis
|
Corvari, Vincent
|
|
2015
|
|
6 |
p. 457-473
17 p.
|
article
|
| 119 |
The establishment and validation of efficient assays for anti-IIa and anti-Xa activities of heparin sodium and heparin calcium
|
Suzuki, Takuo
|
|
2013
|
|
6 |
p. 415-423
9 p.
|
article
|
| 120 |
The long term immunological response of swine after two exposures to a salmon thrombin and fibrinogen hemostatic bandage
|
Rothwell, Stephen W.
|
|
2010
|
|
6 |
p. 619-628
10 p.
|
article
|
| 121 |
The serological evidence in humans supports a negligible risk of zoonotic infection from porcine circovirus type 2
|
Burbelo, Peter D.
|
|
2013
|
|
6 |
p. 430-434
5 p.
|
article
|
| 122 |
The WHO network of collaborating centres on standardization and regulatory evaluation of vaccines
|
Knezevic, Ivana
|
|
2012
|
|
6 |
p. 499-506
8 p.
|
article
|
| 123 |
Treatment of Chlamydia-associated ocular disease via a recombinant protein based vaccine in the koala (Phascolarctos cinereus)
|
Waugh, Courtney
|
|
2016
|
|
6 |
p. 588-590
3 p.
|
article
|
| 124 |
Trypsin diminishes the rat potency of polio serotype 3
|
ten Have, R.
|
|
2015
|
|
6 |
p. 474-478
5 p.
|
article
|
| 125 |
Vaccination of sex reversed hybrid tilapia (Oreochromis niloticus × O. aureus) with an inactivated Vibrio vulnificus vaccine
|
Shoemaker, Craig A.
|
|
2011
|
|
6 |
p. 424-429
6 p.
|
article
|
| 126 |
Vaccine stability study design and analysis to support product licensure
|
Schofield, Timothy L.
|
|
2009
|
|
6 |
p. 387-396
10 p.
|
article
|
| 127 |
Validation of a new alternative for determining in vitro potency in vaccines containing Hepatitis B from two different manufacturers
|
Chovel Cuervo, Mario Landys
|
|
2008
|
|
6 |
p. 375-382
8 p.
|
article
|
| 128 |
Validation of model virus removal and inactivation capacity of an erythropoietin purification process
|
Pérez, Mayté
|
|
2011
|
|
6 |
p. 430-437
8 p.
|
article
|
| 129 |
Vesivirus 2117: Cell line infectivity range and effectiveness of amplification of a potential adventitious agent in cell culture used for biological production
|
Plavsic, Mark
|
|
2016
|
|
6 |
p. 540-545
6 p.
|
article
|
| 130 |
Virus safety of plasma products using 20 nm instead of 15 nm filtration as virus removing step
|
Koenderman, A.H.L.
|
|
2012
|
|
6 |
p. 473-481
9 p.
|
article
|
| 131 |
WHO/Health Canada meeting on regulatory considerations for evaluation and licensing of new meningococcal Group B vaccines, Ottawa, Canada, 3–4 October 2011
|
Feavers, Ian
|
|
2012
|
|
6 |
p. 507-516
10 p.
|
article
|
| 132 |
WHO/KFDA workshop on stability evaluation of vaccines, Seoul, Korea, 23–25 April 2008
|
Shin, Jinho
|
|
2009
|
|
6 |
p. 435-444
10 p.
|
article
|
| 133 |
WHO working group on the quality, safety and efficacy of Japanese encephalitis vaccines (live attenuated) for human use, Bangkok, Thailand, 21–23 February 2012
|
Trent, Dennis W.
|
|
2013
|
|
6 |
p. 450-457
8 p.
|
article
|
Journal description